Clarivate
Clarivate's revenue fell 4.0% to $2.5 billion in fiscal 2025. Its operating margin was 2.9%, up from −10.8% a year earlier. Free cash flow was $365 million, up 2.2%. It paid out $224 million in dividends and buybacks, 61% of free cash flow. The diluted share count fell 2.9%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Clarivate does
Clarivate sells data, software and services to researchers, universities, companies and governments. Its offerings include curated information and analysis, software that automates workflows, and consulting and other services. It also builds AI research assistants and agents that help customers find and check information and run tasks such as literature reviews. It is incorporated in Jersey, with its main offices in London.
It has three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. Most of its revenue comes from subscriptions, where customers pay each year for the right to use its products, and from re-occurring revenue from patent and trademark renewal services. It also sells one-off products, data sets and projects.
The company says it serves more than 45,000 customers worldwide, including academic institutions, libraries, corporations, law firms, government bodies, and drug and medical device companies, and that no single customer or small group is a major part of its business.
Its biggest risks, as it describes them
- Its products rely on data and services from third parties, and those relationships may change.
- New products and services may not win customers.
- It may not get the expected benefits from acquisitions, growth plans or joint ventures.
- Its debt could affect its business and its finances.
- It may not be able to protect or enforce its intellectual property in every country.
Income statement
Clarivate lost money in fiscal 2025: a net loss of $201 million.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 431 | 357 | 371 | 295 | 329 |
| Debt incl. finance leases | 5,567 | 5,071 | 4,770 | 4,571 | 4,470 |
| Net debt (negative means net cash) | 5,136 | 4,714 | 4,400 | 4,276 | 4,141 |
| Net debt to EBITDA | 11.4x | — | — | 9.5x | 5.0x |
| Debt to equity | 0.5x | 0.7x | 0.8x | 0.9x | 0.9x |
| Interest coverage | −0.3x | −14.5x | −2.5x | −1.0x | 0.3x |
| Current ratio | 0.9x | 0.9x | 0.9x | 0.9x | 0.8x |
| Quick ratio | 0.9x | 0.9x | 0.9x | 0.9x | 0.8x |
Cash flow
Projections
Project Clarivate's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, 1 insider bought $1.7 million of Clarivate shares on the open market, and 2 insiders sold $6.0 million, $1.2 million of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Kenneth L. CornickDirector | Bought | 250,000 | $1.85 | $462,500 | Form 4 |
| Aug 6, 2026 | Kenneth L. CornickDirector | Bought | 650,000 | $1.86 | $1.2 million | Form 4 |
| Aug 3, 2026 | Andrew Miles SnyderDirector | Sold | 2,489,618 | $1.94 | $4.8 million | Form 4 |
| Dec 1, 2025 | Bar VeinsteinPresident, A&g | Sold plan | 309,902 | $3.74 | $1.2 million | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 7 of 9 | 5 of 9 | 6 of 9 |
| Rule of 40 | 17.9% | 11.2% | 10.9% |
| Altman Z'' | −1.23 | −1.49 | −1.51 |
| Accruals ratio | −12.4% | −10.6% | −7.3% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Fail |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Pass | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | Fail | Fail |
| Current ratio rose | Pass | Fail | Fail |
| Share count didn't rise | Pass | Fail | Pass |
| Gross margin rose | Pass | Pass | Pass |
| Revenue rose relative to assets | Pass | Pass | Pass |
| F-score | 7 of 9 | 5 of 9 | 6 of 9 |
Compare
Put Clarivate side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Clarivate | FY25 | −4.0% | 2.9% | 14.9% | 0.6% | 5.0x | 6 | |
| UL Solutions | FY25 | 6.4% | 17.1% | 13.2% | 26.8% | 0.3x | 7 | Compare |
| Verisk Analytics | FY25 | 6.6% | 43.7% | 38.8% | 35.5% | 1.6x | 7 | Compare |
| ICF International | FY25 | −7.3% | 7.8% | 6.4% | 8.4% | 2.0x | 7 | Compare |
| Huron Consulting Group | FY25 | 11.7% | 10.5% | 10.8% | 14.5% | 2.3x | 5 | Compare |
9 years of figures
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 918 | 968 | 974 | 1,254 | 1,877 | 2,660 | 2,629 | 2,557 | 2,455 |
| Revenue growth | — | 5.5% | 0.6% | 28.7% | 49.7% | 41.7% | −1.2% | −2.7% | −4.0% |
| Gross profit | — | — | 622 | 815 | 1,251 | 1,706 | 1,722 | 1,688 | 1,622 |
| Research and development | 18 | 14 | — | — | — | — | — | — | — |
| Operating income | −147 | −106 | −82 | −36 | −87 | −3,926 | −735 | −276 | 72 |
| Net income | −264 | −242 | −259 | −351 | −270 | −3,960 | −911 | −637 | −201 |
| Diluted EPS (US$) | — | −1.11 | −0.94 | −0.82 | −0.61 | −6.24 | −1.47 | −0.96 | −0.30 |
| Diluted shares (millions) | 1,641 | 1,646 | 274 | 427 | 641 | 679 | 672 | 694 | 673 |
| Cash flow | |||||||||
| Cash from operations | 7 | −26 | 118 | 264 | 324 | 509 | 744 | 647 | 628 |
| Capital expenditure | 38 | 45 | 70 | 108 | 118 | 203 | 242 | 289 | 263 |
| Free cash flow | −31 | −72 | 48 | 156 | 205 | 306 | 502 | 358 | 365 |
| Dividends paid | 0 | 0 | 0 | 0 | 19 | 75 | 76 | 38 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 159 | 175 | 100 | 200 | 224 |
| Acquisitions | 7 | 24 | 68 | 2,922 | 3,930 | 25 | 5 | 32 | 0 |
| Stock-based compensation | 18 | 14 | 51 | 34 | 33 | 94 | 109 | 60 | 63 |
| Balance sheet at fiscal year end | |||||||||
| Cash and short-term investments | 53 | 26 | 76 | 258 | 431 | 357 | 371 | 295 | 329 |
| Debt incl. finance leases | 1,968 | 1,990 | 1,638 | 3,486 | 5,567 | 5,071 | 4,770 | 4,571 | 4,470 |
| Total assets | 4,005 | 3,710 | 3,791 | 14,791 | 20,183 | 13,945 | 12,707 | 11,490 | 11,069 |
| Total liabilities | 2,719 | 2,659 | 2,543 | 5,756 | 8,257 | 7,132 | 6,714 | 6,351 | 6,226 |
| Shareholders' equity | 1,286 | 1,051 | 1,249 | 9,035 | 11,926 | 6,812 | 5,992 | 5,139 | 4,843 |
| Margins and ratios | |||||||||
| Gross margin | — | — | 63.9% | 65.0% | 66.6% | 64.1% | 65.5% | 66.0% | 66.0% |
| Operating margin | −16.0% | −10.9% | −8.5% | −2.9% | −4.6% | −147.6% | −27.9% | −10.8% | 2.9% |
| Net margin | −28.8% | −25.0% | −26.5% | −28.0% | −14.4% | −148.9% | −34.7% | −24.9% | −8.2% |
| Free cash flow margin | −3.4% | −7.4% | 4.9% | 12.4% | 10.9% | 11.5% | 19.1% | 14.0% | 14.9% |
| Rule of 40 (growth + FCF margin) | — | −1.8% | 5.5% | 41.1% | 60.6% | 53.2% | 17.9% | 11.2% | 10.9% |
| Return on capital | — | −2.7% | −2.2% | −0.4% | −0.5% | −21.7% | −5.3% | −2.2% | 0.6% |
| Return on equity | — | −20.7% | −22.5% | −6.8% | −2.6% | −42.3% | −14.2% | −11.4% | −4.0% |
| Return on assets | — | −6.3% | −6.9% | −3.8% | −1.6% | −23.2% | −6.8% | −5.3% | −1.8% |
| Net debt to EBITDA | 23.5x | 14.9x | 13.2x | 12.1x | 11.4x | — | — | 9.5x | 5.0x |